Coming soon.

Member of cross-functional team charged with mapping out a broad companywide complement therapeutic strategy and indication selection/early development strategies for pipeline molecules.  Lead collaborative initiatives with external researchers to optimize or develop diagnostic and other complement-based assays for key indications.  Lead collaborative initiatives for strategic Phase 4 clinical studies.  Work with BD to evaluate investment opportunities and emerging technologies.